Author: Tobias Gottmann

Recording of RSNA 2019 AI theater presentation | Power food for AI

At this year’s RSNA, Mint Medical presented its AI approach to the audience at the AI theater. Tobias Gottmann and Aditya Jayaram highlighted how every radiological read can contribute to an AI-powered future by seeding power food for AI.   Having mint Lesion in place,…

Mint’s US growth continues – Ms. Andjela Azabagic joins Mint Medical

Mint Medical is further boosting the US business and announces the addition of Andjela Azabagic, as Vice President Business Development, to the US team. Andjela is an experienced business and marketing professional with background in growing domestic and international business and product strategy in the...

Mint-Data for Personalized Medicine at Cancer Center in Tübingen/Germany

Compiling structured real-world-data from different medical disciplines, such as molecular genetics, laboratory medicine, pathology or radiology, to generate insights for specific diseases represents the “holy grail” of Personalized Medicine.   The Cancer Center in Tübingen/Germany initiated the project “Structured data in Oncology” focusing on this...

A look ahead with mint Lesion 3.3

Mint Medical is pleased to announce the recent release of their software product version 3.3 of mint LesionTM which was completed during recent weeks. Mint Medical CEO, Dr. Matthias Baumhauer provides his  insight as to what can be expected in this highly anticipated version of...
Kelie Luby

Mrs. Kelie Luby joins Mint Medical’s team

Mrs. Kelie Luby will join Mint Medical’s team from January 2017 as new Vice President Clinical Trials Software and will be introduced at the upcoming RSNA congress in Chicago.   Kelie is an experienced medical scientist and communicator with more than 18 years of clinical...

Novel oncologic therapy response criteria (iRECIST and more)

Advances in oncology therapies, such as novel immune-related agents, require adapted and refined criteria and guidelines for the assessment and prediction of treatment response.   At RSNA 2016, Mint Medical showcases a comprehensive set of new criteria including mRECIST mesothelioma, the Lugano (Cheson 2014 lymphoma)…

Ann Arbor - Lymph Node Group Location

Customized templates in mint Lesion 3.3

mint Lesion™ 3.3 features a novel data and knowledge modelling core that enables you to customize read procedures and reporting templates – or design them easily yourself.   Among the new oncologic screening and staging guidelines, we introduce comprehensive support for ACR BI-RADS®, a refined…

mint Lesion data

Data Analytics and Instant-Trial Research

Context-driven read procedures in mint Lesion™ facilitate the generation of well-structured data on a large scale. At RSNA 2016, Mint Medical presents a web-based interface to visualize and analyze all acquired data from patients and patient cohorts, as well as usage statistics allowing the monitoring…